Published in J Natl Cancer Inst on May 03, 2006
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43
Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol (2011) 3.22
Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US. Breast Cancer Res Treat (2012) 1.65
Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation. Cancer (2009) 1.59
Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis. World J Gastroenterol (2009) 1.55
Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data. Ann Surg Oncol (2014) 1.48
Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care (2013) 1.36
Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev (2012) 1.15
Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Br J Cancer (2007) 1.05
Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Ann Oncol (2013) 0.97
Colorectal cancer disparities: issues, controversies and solutions. World J Gastroenterol (2014) 0.95
Predictors of short-term postoperative survival after elective colectomy in colon cancer patients ≥ 80 years of age. Ann Surg Oncol (2013) 0.94
Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer. J Geriatr Oncol (2013) 0.94
Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone. Br J Cancer (2012) 0.93
Patterns of colorectal cancer care in the United States and Canada: a systematic review. J Natl Cancer Inst Monogr (2013) 0.93
The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence. Ann Surg (2012) 0.90
Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer (2008) 0.90
Sex- and gender-specific disparities in colorectal cancer risk. World J Gastroenterol (2015) 0.86
Does patient rurality predict quality colon cancer care?: A population-based study. Dis Colon Rectum (2015) 0.85
Validity of the Danish National Registry of Patients for chemotherapy reporting among colorectal cancer patients is high. Clin Epidemiol (2013) 0.84
Comparison of compliance of adjuvant chemotherapy between laparoscopic and open surgery in patients with colon cancer. Ann Coloproctol (2014) 0.84
Factors Affecting Use and Delay (≥8 Weeks) of Adjuvant Chemotherapy after Colorectal Cancer Surgery and the Impact of Chemotherapy-Use and Delay on Oncologic Outcomes. PLoS One (2015) 0.83
Colorectal cancer treatment in older patients. Gastrointest Cancer Res (2007) 0.82
Screening mammography use and chemotherapy among female stage II colon cancer patients: a retrospective cohort study. BMC Health Serv Res (2010) 0.81
Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer. J Gastrointest Cancer (2013) 0.81
Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy? BMC Cancer (2014) 0.81
Re: Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst (2006) 0.80
Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study. Oncologist (2014) 0.79
Coping in Patients With Incurable Lung and Gastrointestinal Cancers: A Validation Study of the Brief COPE. J Pain Symptom Manage (2016) 0.79
Lower body mass index predicts worse cancer-specific prognosis in octogenarians with colorectal cancer. J Gastroenterol (2015) 0.78
Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy. Oncotarget (2016) 0.78
Completion rates of adjuvant chemotherapy for colon cancer: a historical perspective. J Natl Cancer Inst (2006) 0.77
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer. Pharmacoeconomics (2014) 0.76
Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer. Cancer Nurs (2015) 0.76
Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study. Cancer (2017) 0.75
Effect of laparoscopic surgery on the initiation and completion of chemotherapy in patients with colon cancer. Ann Coloproctol (2014) 0.75
The impact of delayed chemotherapy on its completion and survival outcomes in stage II colon cancer patients. PLoS One (2014) 0.75
Colorectal cancer treatment in the elderly: tailored therapy approaches. Gastrointest Cancer Res (2007) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA (1998) 26.79
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care (2002) 21.63
Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol (1993) 13.16
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care (1993) 9.72
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med (2001) 7.59
NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA (1990) 5.77
Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst (2001) 3.65
Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care (2002) 3.36
Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA (2000) 3.18
Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol (2003) 3.18
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg (2002) 2.71
Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol (2002) 2.51
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51
Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol (2002) 2.33
Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health (2000) 2.26
Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol (1997) 2.21
Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer (2001) 2.12
Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst (2001) 2.10
Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol (1998) 2.05
Marriage, widowhood, and health-care use. Soc Sci Med (2003) 2.03
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89
Construct validity of medicare chemotherapy claims: the case of 5FU. Med Care (2002) 1.87
Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer (1998) 1.85
Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer (2004) 1.80
Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol (2003) 1.73
Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol (1999) 1.59
The National Cancer Data Base. Report on colon cancer. Cancer (1996) 1.53
Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet (2000) 1.39
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst (2002) 1.38
Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer (1983) 1.14
Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma. Cancer (2005) 1.13
Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial. Cancer (1995) 1.12
Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol (1991) 1.11
Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy. Cancer Chemother Pharmacol (1998) 1.06
Study of completeness of the surveillance, epidemiology and end results (SEER) program case ascertainment by hospital size and casefinding source. Health Rep (1993) 1.06
Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant (2002) 1.05
Colon cancer treatment in rural North and South Carolina. Cancer Detect Prev (1999) 0.98
Life course transitions and depressive symptoms among women in midlife. Int J Aging Hum Dev (2004) 0.95
Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. Eur J Cancer (1992) 0.93
Predictors of Pap smear screening in socioeconomically disadvantaged elderly women. J Am Geriatr Soc (1995) 0.83
Adjuvant Treatment of Colorectal Cancer in the Elderly. Cancer Control (1995) 0.83
Guideline for the management of ingested foreign bodies. Gastrointest Endosc (2002) 9.03
Management of ingested foreign bodies and food impactions. Gastrointest Endosc (2011) 6.08
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc (2009) 2.84
Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst (2008) 2.84
Sedation and anesthesia in GI endoscopy. Gastrointest Endosc (2008) 2.73
The role of endoscopy in the management of obscure GI bleeding. Gastrointest Endosc (2010) 2.68
Complications of ERCP. Gastrointest Endosc (2012) 2.61
In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care (2006) 2.53
Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol (2003) 2.43
An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 2.18
Complications of colonoscopy. Gastrointest Endosc (2011) 2.12
The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc (2010) 2.11
Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc (2008) 2.08
Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst (2005) 2.08
Infection control during GI endoscopy. Gastrointest Endosc (2008) 2.07
The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc (2012) 2.01
Disparities in infant health among American Indians and Alaska natives in US metropolitan areas. Pediatrics (2002) 1.91
Accuracy of Medicare claims for identifying findings and procedures performed during colonoscopy. Gastrointest Endosc (2010) 1.91
Complications of ERCP. Gastrointest Endosc (2003) 1.84
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship. Arch Surg (2007) 1.73
Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med (2003) 1.73
Adverse events of upper GI endoscopy. Gastrointest Endosc (2012) 1.72
Specialty differences in polyp detection, removal, and biopsy during colonoscopy. Am J Med (2010) 1.71
Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg (2010) 1.68
Access to cancer services for rural colorectal cancer patients. J Rural Health (2008) 1.68
Complications of colonoscopy. Gastrointest Endosc (2003) 1.65
Improved reflexive testing algorithm for hepatitis C infection using signal-to-cutoff ratios of a hepatitis C virus antibody assay. Clin Chem (2011) 1.62
Complications of colonoscopy: magnitude and management. Gastrointest Endosc Clin N Am (2010) 1.59
Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors. Hepatology (2007) 1.55
Preparation of patients for GI endoscopy. Gastrointest Endosc (2003) 1.54
Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc (2002) 1.54
The role of endoscopy in the management of acute non-variceal upper GI bleeding. Gastrointest Endosc (2012) 1.53
Estrogen therapy and risk of cardiovascular events among women with type 2 diabetes. Diabetes Care (2003) 1.52
Reoperation as a quality indicator in colorectal surgery: a population-based analysis. Ann Surg (2007) 1.51
Diffusion of computer-aided mammography after mandated Medicare coverage. Arch Intern Med (2010) 1.50
Acute colonic pseudo-obstruction. Gastrointest Endosc (2002) 1.50
Treatment of severe snoring with a combination of pseudoephedrine sulfate and domperidone. J Clin Sleep Med (2006) 1.48
Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer (2007) 1.47
Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study. Cancer (2011) 1.47
Failure of health care professionals to interpret fecal occult blood tests accurately. Am J Med (2003) 1.46
Trends in colorectal cancer testing among Medicare subpopulations. Am J Prev Med (2008) 1.46
Endoscopy by nonphysicians. Gastrointest Endosc (2009) 1.42
Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection. Dig Dis Sci (2013) 1.41
Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol (2006) 1.37
Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med (2014) 1.36
Growth of ambulatory surgical centers, surgery volume, and savings to medicare. Am J Gastroenterol (2013) 1.36
Streamlining research by using existing tools. Clin Transl Sci (2011) 1.36
Professional liability issues and practice patterns of obstetric providers in Washington State. Obstet Gynecol (2006) 1.32
Delivery of cancer screening: how important is the preventive health examination? Arch Intern Med (2007) 1.31
Partnership-driven Resources to Improve and Enhance Research (PRIMER): a survey of community-engaged researchers and creation of an online toolkit. Clin Transl Sci (2011) 1.31
ERCP core curriculum. Gastrointest Endosc (2006) 1.30
The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc (2011) 1.28
Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med (2010) 1.27
The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology (2004) 1.26
Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Ann Intern Med (2013) 1.26
Methods of granting hospital privileges to perform gastrointestinal endoscopy. Gastrointest Endosc (2002) 1.25
Modifications in endoscopic practice for pediatric patients. Gastrointest Endosc (2008) 1.25
Complications of upper GI endoscopy. Gastrointest Endosc (2002) 1.24
The interface of primary and oncology specialty care: from diagnosis through primary treatment. J Natl Cancer Inst Monogr (2010) 1.24
Persistent racial and ethnic disparities in up-to-date colorectal cancer testing in medicare enrollees. J Am Geriatr Soc (2009) 1.24
Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg (2004) 1.24
Role of EUS. Gastrointest Endosc (2007) 1.23
Tethered capsule endoscopy, a low-cost and high-performance alternative technology for the screening of esophageal cancer and Barrett's esophagus. IEEE Trans Biomed Eng (2008) 1.23
Gender-related factors in the recruitment of physicians to the rural Northwest. J Am Board Fam Pract (2002) 1.23
Appropriate use of GI endoscopy. Gastrointest Endosc (2012) 1.22
Reality check: perceived versus actual performance of community mammographers. AJR Am J Roentgenol (2006) 1.20
Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study. Am J Public Health (2008) 1.19
Hepatitis C virus infection and the prevalence of renal insufficiency. Clin J Am Soc Nephrol (2007) 1.18
Quality indicators common to all GI endoscopic procedures. Gastrointest Endosc (2014) 1.17
Scanning single fiber endoscopy: a new platform technology for integrated laser imaging, diagnosis, and future therapies. Gastrointest Endosc Clin N Am (2008) 1.16
Improving the concordance of mammography assessment and management recommendations. Radiology (2006) 1.15
The effect of periodic monitoring and feedback on screening colonoscopy withdrawal times, polyp detection rates, and patient satisfaction scores. Gastrointest Endosc (2010) 1.15
Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology (2003) 1.12
Community-based mammography practice: services, charges, and interpretation methods. AJR Am J Roentgenol (2005) 1.12
Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations? Ann Intern Med (2012) 1.12
Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines. Inflamm Bowel Dis (2011) 1.11
Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med (2002) 1.11
Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol (2005) 1.09
Continuity of care and cancer screening among health plan enrollees. Med Care (2008) 1.09
The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc (2013) 1.09
Role of endoscopy in the bariatric surgery patient. Gastrointest Endosc (2008) 1.08
The role of endoscopy in gastroduodenal obstruction and gastroparesis. Gastrointest Endosc (2011) 1.07
Contrasting US and European approaches to colorectal cancer screening: which is best? Gut (2010) 1.07
Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C. Neurosci Lett (2004) 1.07
Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology (2006) 1.07